Evidence map›Paper›PMID 39287756›Full record

ArticleEndocrine2024

Comparison of clinical, hormonal, pathological and treatment outcomes of ectopic Cushing's syndrome by sex: results of a multicenter study.

Sema Ciftci, Nusret Yilmaz, Ozlem Soyluk Selcukbiricik, Zeliha Hekimsoy, Asena Gökcay Canpolat, Senay Topsakal, Guzin Fidan Yaylali, Fuat Misiroglu, Nurdan Gul, Ayse Kubat Uzum and 10 more

Abstract readMulticenter StudyComparative Study
PubMed Publisher
In one paragraph

Article in Endocrine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Sema CiftciBakirkoy Dr. Sadi Konuk Training and Research Hospital, Department of Endocrinology and Metabolism, University of Health Sciences, Istanbul, Turkey. sdogansen@gmail.com.
Nusret YilmazSchool of Medicine, Department of Endocrinology and Metabolism, Akdeniz University, Antalya, Turkey.
Ozlem Soyluk SelcukbiricikDepartment of Endocrinology and Metabolism, Istanbul University Faculty of Medicine, Istanbul, Turkey.
Zeliha HekimsoyDepartment of Endocrinology and Metabolism, Manisa Celal Bayar University, Manisa, Turkey.
Asena Gökcay CanpolatDepartment of Endocrinology and Metabolism, Ankara University School of Medicine, Ankara, Turkey.
Senay TopsakalFaculty of Medicine, Department of Endocrinology and Metabolism, Pamukkale University, Denizli, Turkey.
Guzin Fidan YaylaliFaculty of Medicine, Department of Endocrinology and Metabolism, Pamukkale University, Denizli, Turkey.
Fuat MisirogluBakirkoy Dr. Sadi Konuk Training and Research Hospital, Department of Endocrinology and Metabolism, University of Health Sciences, Istanbul, Turkey.
Nurdan GulDepartment of Endocrinology and Metabolism, Istanbul University Faculty of Medicine, Istanbul, Turkey.
Ayse Kubat UzumDepartment of Endocrinology and Metabolism, Istanbul University Faculty of Medicine, Istanbul, Turkey.
Ayşa HaciogluDepartment of Endocrinology and Metabolism, Erciyes University School of Medicine, Kayseri, Turkey.
Goknur YorulmazDepartment of Endocrinology and Metabolism, Eskişehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey.
Hatice OzisikDepartment of Endocrinology and Metabolism, Ege University Faculty of Medicine, Izmir, Turkey.
Banu Sarer YurekliDepartment of Endocrinology and Metabolism, Ege University Faculty of Medicine, Izmir, Turkey.
Zafer PekkolayDepartment of Endocrinology and Metabolism, Dicle University Faculty of Medicine, Diyarbakir, Turkey.
Seda TurgutBakirkoy Dr. Sadi Konuk Training and Research Hospital, Department of Endocrinology and Metabolism, University of Health Sciences, Istanbul, Turkey.
Zuleyha KaracaDepartment of Endocrinology and Metabolism, Erciyes University School of Medicine, Kayseri, Turkey.
Cevdet DuranDepartment of Endocrinology and Metabolism, Medical School of Usak University, Usak, Turkey.
Medine Nur KebapciDepartment of Endocrinology and Metabolism, Eskişehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey.
Sema YarmanDepartment of Endocrinology and Metabolism, Istanbul University Faculty of Medicine, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare clinical and hormonal data, neuroendocrine neoplasia (NEN) localization, treatment, and survival outcomes in ectopic Cushing's syndrome (ECS) by sex.

methodsEleven experienced centers from our country participated in this retrospective study. The clinical and hormonal features, tumor imaging, pathological results, treatment modalities, and disease courses of the patients were evaluated.

results28 female and 26 male patients with ECS were compared. The mean age at diagnosis, clinical characteristics, and hormonal evaluation results were similar. However, insulin-requiring diabetes mellitus (p = 0.04) and osteoporosis with fractures were more common in males (p = 0.03). While more patients with increased DHEA-S levels than the upper limit of normal were found to be higher in females, central hypothyroidism were higher in males (p = 0.02). At the diagnosis, 36 NENs (68% of females and 69% of males) were localized. Small cell lung carcinoma was higher in males (p = 0.02), and the frequency of other NENs was not different. Curative surgery was performed on 61% of females and 46% of males. Tumor size, Ki-67 labeling index, positive ACTH immunostaining, local lymph node and distant metastasis rates were similar in both sexes. In the follow-up, the tumor became visible in 7 of 10 females and 4 of 8 males after medical treatment and/or bilateral adrenalectomy. The remission rates (65% of females, 62% of males) and NEN-related death rates (14% of females, 30% of males) were similar.

conclusionWhile ECS has a similar disease course in many aspects in males and females, hyperglycemia and osteoporosis are more severe in males.

Indexed as

Cushing SyndromeACTH Syndrome, EctopicAdultAgedFemaleHumansMaleMiddle AgedNeuroendocrine TumorsRetrospective StudiesSex FactorsTreatment OutcomeYoung AdultCushing’s syndromeEctopic ACTH syndromeNeuroendocrine neoplasiaNeuroendocrine tumorSex difference

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.